-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
[ Focus on Chemical Machinery Equipment Network ] As cost reduction has become the subject of medical reform, innovative applications of digital technology in the field of biomedicine are becoming more common.
The industry has reached consensus that digital innovation has become the "standard configuration" of multinational pharmaceutical companies in the Chinese market.
At present, multinational pharmaceutical giants including Sanofi, Takeda, Pfizer, Johnson & Johnson have put forward digital strategies, and have used various methods to improve the level of business digitalization and accelerate the pace of digital innovation.
Chemical machinery and equipment network hotspots pay attention to chemical machinery and equipmentThe industry has reached consensus that digital innovation has become the "standard configuration" of multinational pharmaceutical companies in the Chinese market.
At present, multinational pharmaceutical giants including Sanofi, Takeda, Pfizer, Johnson & Johnson have put forward digital strategies, and have used various methods to improve the level of business digitalization and accelerate the pace of digital innovation.
Among them, Sanofi has been implementing digital innovation around hierarchical diagnosis and treatment, medical and health service network construction, and diabetes management since 2014.
In 2018, after the establishment of the first digital innovation center "Extreme Innovation Alliance", Sanofi initially empowered the grassroots and promoted hierarchical diagnosis and treatment, while working with start-ups to promote internal and external innovation.
It is reported that Sanofi is currently increasing its efforts in the field of digitalization + chronic disease management/primary medical care to further penetrate the Chinese market.
In 2018, after the establishment of the first digital innovation center "Extreme Innovation Alliance", Sanofi initially empowered the grassroots and promoted hierarchical diagnosis and treatment, while working with start-ups to promote internal and external innovation.
It is reported that Sanofi is currently increasing its efforts in the field of digitalization + chronic disease management/primary medical care to further penetrate the Chinese market.
With the wave of digital innovation sweeping the pharmaceutical industry, Takeda Pharmaceuticals is also deeply involved in it, committed to building a patient-centered and innovative-driven pharmaceutical company to escort a healthy life and a better future.
Among them, in the Takeda market, it is mainly deployed in AI+ new drugs, patient services, and innovation incubators.
In the Chinese market, Takeda has implemented the "N3" innovation strategy through New Model (new model), New Tool (new tool), and New Service.
(New Service) to open up internal and external businesses and provide better solutions for all parties in the pharmaceutical value chain.
Among them, in the Takeda market, it is mainly deployed in AI+ new drugs, patient services, and innovation incubators.
In the Chinese market, Takeda has implemented the "N3" innovation strategy through New Model (new model), New Tool (new tool), and New Service.
(New Service) to open up internal and external businesses and provide better solutions for all parties in the pharmaceutical value chain.
Pfizer actively promotes "digital transformation".
In a special period of 2020, Pfizer uses digital means to launch the SAFE patient safety service platform, where patients can solve various questions during the treatment process; convenient and fast online drug purchase maps, convenient for people to find Medicine (cloud pharmacy) and other patient services.
On November 7, 2020, Pfizer also announced that it has officially launched a strategic cooperation with Alibaba Health.
The two parties will work together to create an innovative model of large-scale vaccination and form a complete online, full-chain, high-quality vaccination service.
The model covers online disease education, expert consultation, sharing and communication, online appointments and other links, forming a complete closed-loop service.
At the same time, it further explores the promotion and expansion of non-public vaccines to help more Chinese patients.
In a special period of 2020, Pfizer uses digital means to launch the SAFE patient safety service platform, where patients can solve various questions during the treatment process; convenient and fast online drug purchase maps, convenient for people to find Medicine (cloud pharmacy) and other patient services.
On November 7, 2020, Pfizer also announced that it has officially launched a strategic cooperation with Alibaba Health.
The two parties will work together to create an innovative model of large-scale vaccination and form a complete online, full-chain, high-quality vaccination service.
The model covers online disease education, expert consultation, sharing and communication, online appointments and other links, forming a complete closed-loop service.
At the same time, it further explores the promotion and expansion of non-public vaccines to help more Chinese patients.
Digital strategy is currently one of the most important strategies for Johnson & Johnson's major businesses.
In 2020, as new challenges emerge in the medical industry and patients' habits of seeing a doctor change, Johnson & Johnson has also joined the runway of Internet hospitals.
It is reported that in addition to the original business model, Johnson & Johnson's pharmaceutical business is actively expanding the Internet hospital and other models to provide patients with services such as online consultation and dispensing.
At the same time, Johnson & Johnson Medical is also accelerating the construction of digital diagnosis and treatment, digital professional education, digital surgery, etc.
, and strive to build the Chinese market into a digital development engine.
In 2020, Johnson & Johnson achieved the sales of the first Tianzhihang orthopedic surgery robot in China, and officially launched the Tianzhihang Robot-assisted Spinal Surgery Clinical Technology Application Center in Shanghai Renji Hospital.
In addition, the company's pharmaceutical company Xi'an Janssen and the First Affiliated Hospital of Xi'an Jiaotong University signed a memorandum of cooperation to jointly explore a new model of patient-centric Internet hospitals.
In 2020, as new challenges emerge in the medical industry and patients' habits of seeing a doctor change, Johnson & Johnson has also joined the runway of Internet hospitals.
It is reported that in addition to the original business model, Johnson & Johnson's pharmaceutical business is actively expanding the Internet hospital and other models to provide patients with services such as online consultation and dispensing.
At the same time, Johnson & Johnson Medical is also accelerating the construction of digital diagnosis and treatment, digital professional education, digital surgery, etc.
, and strive to build the Chinese market into a digital development engine.
In 2020, Johnson & Johnson achieved the sales of the first Tianzhihang orthopedic surgery robot in China, and officially launched the Tianzhihang Robot-assisted Spinal Surgery Clinical Technology Application Center in Shanghai Renji Hospital.
In addition, the company's pharmaceutical company Xi'an Janssen and the First Affiliated Hospital of Xi'an Jiaotong University signed a memorandum of cooperation to jointly explore a new model of patient-centric Internet hospitals.
Original title: Break down the strategic layout of multinational pharmaceutical giants in terms of digitalization
